Klingman & Associates’s Corteva CTVA Stock Holding History
Bought
Maintained
Sold
Other funds holding CTVA
Klingman & Associates's CTVA Position: Q3 2026 in Review
Klingman & Associates increased its Corteva (CTVA) stake by 0.74% in Q3 2026, buying an estimated $3.06K and bringing the position to 5,018 shares worth $390K. The position accounts for 0.02% of the portfolio, ranked #263.
Klingman & Associates first reported a position in CTVA in Q3 2024 and has held it in 9 quarters since. The position peaked at $422K in Q2 2026. 477 funds tracked by Wall St. Rank hold CTVA as of Q3 2026.
- Klingman & Associates held 5,018 shares of Corteva worth $390K as of Q3 2026.
- Klingman & Associates bought 37 Corteva shares in Q3 2026, an estimated $3.06K.
- Corteva made up 0.02% of Klingman & Associates's portfolio in Q3 2026, its #263 holding.
- Klingman & Associates first reported a position in Corteva in Q3 2024 and has held it in 9 quarters since.
- Klingman & Associates's Corteva position peaked at $422K in Q2 2026.
- 477 funds tracked by Wall St. Rank held Corteva as of Q3 2026.
Based on Klingman & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.